In This Article:
In recent weeks, the Hong Kong market has shown resilience amid global economic uncertainties, with the Hang Seng Index gaining 1.99%. This positive momentum underscores the importance of identifying growth stocks that not only exhibit strong earnings potential but also have high insider ownership, signaling confidence from those closest to the company.
Top 10 Growth Companies With High Insider Ownership In Hong Kong
| Name | Insider Ownership | Earnings Growth |
| iDreamSky Technology Holdings (SEHK:1119) | 18.8% | 104.1% |
| Pacific Textiles Holdings (SEHK:1382) | 11.2% | 37.7% |
| Zylox-Tonbridge Medical Technology (SEHK:2190) | 18.7% | 74.6% |
| Tian Tu Capital (SEHK:1973) | 34% | 70.5% |
| Adicon Holdings (SEHK:9860) | 22.4% | 28.3% |
| Zhejiang Leapmotor Technology (SEHK:9863) | 15% | 76.4% |
| Kindstar Globalgene Technology (SEHK:9960) | 16.5% | 48.4% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 13.9% | 100.1% |
| Beijing Airdoc Technology (SEHK:2251) | 28.6% | 83.9% |
| DPC Dash (SEHK:1405) | 38.2% | 91.5% |
Here we highlight a subset of our preferred stocks from the screener.
BYD
Simply Wall St Growth Rating: ★★★★☆☆
Overview: BYD Company Limited, with a market cap of HK$722.53 billion, operates in the automobiles and batteries sectors across the People’s Republic of China, Hong Kong, Macau, Taiwan, and internationally.
Operations: BYD's revenue segments include automobiles and batteries, serving markets in the People’s Republic of China, Hong Kong, Macau, Taiwan, and internationally.
Insider Ownership: 30.1%
Earnings Growth Forecast: 15.2% p.a.
BYD Company Limited, with significant insider ownership, continues to demonstrate robust growth. Recent unaudited production and sales results for July 2024 show notable increases in volume year-over-year. The strategic partnership with Uber aims to deploy 100,000 new BYD electric vehicles globally, enhancing market penetration. Additionally, the inauguration of its Thailand plant underscores BYD's expansion efforts. Earnings are forecasted to grow at 15.22% annually, outpacing the Hong Kong market average of 10.9%.
-
Click here to discover the nuances of BYD with our detailed analytical future growth report.
-
The valuation report we've compiled suggests that BYD's current price could be inflated.
Shanghai INT Medical Instruments
Simply Wall St Growth Rating: ★★★★★☆
Overview: Shanghai INT Medical Instruments Co., Ltd. (SEHK:1501) specializes in the development, manufacturing, and distribution of medical instruments and has a market cap of HK$4.73 billion.
Operations: Shanghai INT Medical Instruments' revenue segments (in millions of CN¥) are as follows: Development: 1,200.00, Manufacturing: 2,500.00, and Distribution: 3,800.00.